Back to top

Chemed's Roto-Rooter & VITAS Robust, Acuity Mix Shift Weak

Read MoreHide Full Article

On Jul 15, we issued an updated research report on Chemed Corporation (CHE - Free Report) . The company currently operates two wholly-owned subsidiaries, namely VITAS Healthcare and Roto-Rooter.

Over the past three months, shares of Chemed have consistently outperformed its industry. The stock has gained 9.5% compared with the industry’s 3.5% rise. Chemed exited 2018 on a promising note. The company generated strong year-over-year growth in revenues. It is optimistic to note that it witnessed a solid revenue uptick across its key subsidiaries.

VITAS has been registering an expanded average daily census. Moreover, the Roto-Rooter business has been seeing growth on the back of a solid performance by the core plumbing and drain cleaning service segments as well as a robust trend in water restoration.

Moreover, we are upbeat about Roto-Rooter, which is currently the nation's leading provider of plumbing and drain cleaning services. Through its network of company-owned branches, independent contractors and franchises, Roto-Rooter offers plumbing and drain cleaning services to more than 90% of the U.S. population.

On the flip side, Chemed ended first-quarter 2019 on a dull note. Both earnings and revenues missed the respective Zacks Consensus Estimate in the reported quarter. An unfavorable acuity mix shift, fluctuations in net room and board plus contractual adjustments dented the top line during the period.

Chemed's capital deployment policy is based on its suitable buyouts and a solid return of cash to shareholders through dividends and buybacks. 

Zack Rank and Key Picks

Chemed currently curries a Zacks Rank #3 (Hold). A few better-ranked stocks in the broader medical space are Teleflex Inc. (TFX - Free Report) , Penumbra (PEN - Free Report) and NuVasive Corporation (NUVA - Free Report) . While Teleflex currently carries a Zacks Rank #2 (Buy), the other two sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Teleflex’s long-term earnings growth rate is expected at 13.7%.

Penumbra’s long-term earnings growth rate is projected at 21.5%.

NuVasive’s long-term earnings growth rate is expected to be 11.9%.

Radical New Technology Creates $12.3 Trillion Opportunity

 Imagine buying Microsoft stock in the early days of personal computers… or Motorola after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors. Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.

See the 7 breakthrough stocks now>>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Teleflex Incorporated (TFX) - free report >>

Penumbra, Inc. (PEN) - free report >>

NuVasive, Inc. (NUVA) - free report >>

Chemed Corporation (CHE) - free report >>